IBM (IBM) director reports 309 deferred Promised Fee Shares in Form 4 filing
Rhea-AI Filing Summary
International Business Machines Corporation director activity on 12/31/2025 involved a routine board compensation deferral rather than an open-market trade. The director acquired 309 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan, which are derivative securities tied to IBM common stock.
Each Promised Fee Share represents the right to receive an equivalent number of IBM common shares or cash, with payout deferred until the director retires. After this transaction, the director beneficially owned 3,529 Promised Fee Shares on a direct basis. The transaction reflects fees being converted into deferred equity-based compensation according to the plan’s terms.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Promised Fee Share | 309 | $296.21 | $92K |
Footnotes (1)
- Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.
FAQ
What insider transaction did IBM (IBM) report for 12/31/2025?
IBM reported that a director acquired 309 Promised Fee Shares on 12/31/2025 under the IBM Board of Directors Deferred Compensation and Equity Award Plan. These represent deferred compensation rather than a market purchase.
Did the IBM (IBM) director buy common stock on the open market?
No. The filing shows an acquisition of Promised Fee Shares as part of fee deferral under IBM’s Board of Directors Deferred Compensation and Equity Award Plan, not an open-market purchase of common stock.